India: Delhi High Court Says Exact Use Of Trademark Needed To Constitute Trademark Infringement

Last Updated: 22 August 2018
Article by S.S. Rana & Co. Advocates

Recently, the Delhi High Court in the case of Mankind Pharma Ltd Vs. Chandra Mani Tiwari and Anr. held that 'to constitute infringement under Section 29(5), it is required to have the same or identical trade name and merely having a similar or deceptively similar trademark to the registered trademark would not constitute infringement.'

Brief Facts

  • Mankind Pharma Ltd. (hereinafter referred to as 'the Plaintiff') was the registered proprietor of the mark 'MANKIND' in 42 different classes. It had been using it for three decades by adding prefix or suffix to the elements 'MANKIND' and/or 'KIND'.
  • Around November 5, 2016, the Plaintiff, while going through the record of the Trade Marks Registry, found out that the trade name 'MERCYKIND PHARMACEUTICALS PRIVATE LIMITED' (hereinafter referred to as 'Defendant No. 2') belonged to Chandra Mani Tiwari (hereinafter referred to as the 'Defendant No. 1'), who was the director of Defendant No. 2.
  • The Defendant no. 2 was doing business under the trademarks such as 'MERCYMOX', 'MERCYCOUGH' and 'MERCYCOPE.
  • Cease and Desist letters were sent to the Defendants. However, it refused to comply giving false and frivolous reason.
  • Therefore, the Plaintiff instituted a suit against the Defendants before the Delhi High Court (hereinafter referred to as 'the Court') seeking permanent injunction to restrain the Defendants from infringing the Plaintiff's trade mark/trade name 'MANKIND' and series of marks with the suffix/prefix 'KIND' and from passing off their business/goods as that of the Plaintiff, by adopting and using the trade name 'MERCYKIND PHARMACEUTICAL PRIVATE LIMITED' or in any other manner whatsoever thereby.


Whether the Defendant is guilty of infringing the Plaintiff's trademark and passing off of the Plaintiff's goods by using the word 'KIND' in his tradename of "MERCYKIND"?

Plaintiff's Contentions

  • It was contended that the Defendants were carrying on their business by impersonating themselves to be under the umbrella of the Plaintiff.
  • It was contended that the trade name 'MERCYKIND PHARMACEUTICAL PRIVATE LIMITED' was deceptively similar to the Plaintiff's corporate name/trade name 'MANKIND PHARMA LIMITED'.
  • It argued that any trade name in the pharmaceutical company containing the element 'KIND' would amount to dilution of the Plaintiff's well-known trademark and result in infringement and/or passing off the Plaintiff's reputed trade name 'MANKIND'.

Defendant's Contentions

  • It contended that on doing a mere search of the online records of the Registrar of Trade Marks in Class 05 would reveal that there are over 120 trademarks registered or pending, other than the registrations or applications in the name of the Plaintiff, in the names of several other entities/individuals, each of whom have registered or have applied for registration of marks with the suffix 'KIND'.
  • It argued that on seeing its corporate name 'MERCYKIND PHARMACEUTICALS PRIVATE LIMITED', as a whole, had no deceptive similarity with the Plaintiff's trademark 'MANKIND'.
  • It further argued that mere presence of a publici juris term 'KIND' does not make the marks of the Plaintiff and the Defendant deceptively similar.
  • It submitted that, in the course of its business, it coined and adopted several unique, distinctive and eye catchy trademarks with prefix 'MERCY' to market its medicinal and pharmaceutical preparations.
  • It contended that the Plaintiff did not hold any registration for the word 'KIND' per se and its trade name 'MERCYKIND' did not constitute infringement within the meaning of Section 29(5) of the Trade Marks Act, 1999.
  • It submitted that if 'ATORKIND' and 'ATORVAKIND' were visually, structurally and phonetically different, as admitted by the Plaintiff in the reply to the Examination Report of the Registrar of Trade Marks on the application of the Plaintiff for registration of "ATORVAKIND", then 'MERCYKIND' and 'MANKIND' cannot be the same.

Court's Decision

  • The Court noted that the Plaintiff took a stand 'ATORVAKIND' is different from 'ATORKIND'. This according to the Court was a relevant fact to be considered for the purposes of interim injunction. Therefore, the Court held that since Plaintiff concealed this fact, it was disentitled to any equitable relief.
  • The Court analyzed the question that whether the affixation of the name of the Defendant No.2 with the word 'MERCYKIND' amount to use as a trade mark for the purposes of Section 29 of the Trade Marks Act, 1999?
  • The question was answered by Court in negative. It held that 'mere affixation of the name of the Defendant No.2 as manufacturer or marketeer of the drugs/medicines sold by the Defendants would not qualify as a use thereof as a trade mark even under Section 29(6) of the Act.'
  • The Court also opined that drugs are prescribed by doctors by their generic name and not trade name, and hence the showing of manufacturer's name in the drug was of not much consequence.

On the point of violation of Section 29(6) of the Trademarks Act, the Court held that 'The Legislature, inspite of having used the words 'identical with, or deceptively similar to' in Section 29(1) to (4), having used different words in Section 29(5) and having not used such words in Section 29(5), is deemed to have not constituted use as name or part of the name, of a word or mark deceptively similar to the registered trade mark of the Plaintiff, as infringement thereof by the Defendants. What has been constituted as infringement under Section 29(5) is use of the registered trade mark as trade name or part of the trade name. Thus, there would have been infringement under Section 29(5), if the Defendants, as part of their name, had used 'MANKIND' or any other registered trade mark of the Plaintiff. Merely because 'MERCYKIND' in the name of Defendant No.2 Company may be deceptively similar to 'MANKIND' or any other registered trade mark of Plaintiff with 'KIND' as prefix or suffix, would not amount to infringement under Section 29(5).'

Therefore, distinguishing between cases of infringement by use of 'trade name' under Section 29(5) of the Trade Marks Act, and the cases of infringement by use of 'trademark' under sub-sections (1) to (4) of Section 29, the Court held that 'to make out a case of infringement by use of 'trade name' under Section 29(5), mere similarity or deceptive similarity with the registered trademark was not sufficient and that there has to be exact use of registered trademark or part of it as the trade name of the business. The test of "similarity or deceptive similarity" was applicable only for cases of infringement by use of 'trade mark' covered by sub-sections (1) to (4) of Section 29.'

For further information please contact at S.S Rana & Co. email: or call at (+91- 11 4012 3000). Our website can be accessed at

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

S.S. Rana & Co. Advocates
Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
Email Address
Company Name
Confirm Password
Mondaq Newsalert
Select Topics
Select Regions
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions